Autolus Therapeutics plc (NASDAQ:AUTL) Q1 2023 Earnings Call

Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics First Quarter 2023 Financial Results Conference Call and Operational Progress.

Related Keywords

Switzerland , Mizuho , Hokkaido , Japan , Chicago , Illinois , United States , London , City Of , United Kingdom , Stevenage , Hertfordshire , Spain , Lugano , Ticino , American , Mara Goldstein , Alexandra Deschner , John Johnson , Gil Blum , Chris Van , Lucinda Crabtree , Kelly Shi , William Blair , Lori Muffly , Sara Ghorashian , Yanan Zhu , Claire Roden , Matthew Gitlin , Matthew Phipps , Andreas Mackensen , Drug Administration , Needham Company , Silicon Valley Bank , American Society Of Hematology , Stanford University , Blackstone Life Sciences , Us Cardinal Health , European Hematology Association Congress , Nasdaq , International Conference For Malignant Lymphoma In Lugano , Autolus Therapeutics Plc , Cardinal Health , University Of Erlangen Germany , Autolus Therapeutics , Call Transcript May , Autolus Therapeutics First Quarter , Results Conference Call , Investor Relations , Investor Relations Consultant , Christian Itin , Chief Executive Officer , Chief Financial , Private Securities Litigation Reform Act , American Society , Clinical Oncology Annual Meeting , Claire Rode , Tandem Meetings , Erlangen Germany , European Bone Marrow , Transplant Meeting , Great Ormond Street Hospital , Molecular Therapy , International Conference , Malignant Lymphoma , Annual Shareholder , Autolus Board , Capital Markets Day , Professor Lori Muffly , Autolu Chief Operating Officer , Moderna Cabaletta , Wells Fargo , Asthika Goonewardene ,